CELESTICA INC (CLS) Cash Flow Statement
CELESTICA INC (CLS) generated $1.1B of operating cash flow over the twelve months to 2026-06-30, spent $625.3M on capital expenditure and had free cash flow of $518.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLSCELESTICA INCFollow CLS — free
—
Price chart with a free account
- Market cap
- 29.9B
- P/E TTM
- 27.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
| Line | FY2017 Dec 17 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Operating cash flow | — | 0.33 | 0.47 | 0.66 | 1.14 | |
| Capital expenditure | — | 0.13 | 0.17 | 0.20 | -0.63 | |
| Free cash flow | — | 0.20 | 0.30 | 0.46 | 0.52 | |
| Share repurchases | — | 0.04 | 0.15 | 0.15 | — | |
| Stock-based compensation | — | 0.06 | 0.06 | 0.07 | — |
USD billions · SEC XBRL
CELESTICA INC — questions
- What is CELESTICA INC's operating cash flow?
- $1.1B over the twelve months to 2026-06-30.
- How much does CELESTICA INC spend on capital expenditure?
- $625.3M over the twelve months to 2026-06-30.
- What is CELESTICA INC's free cash flow?
- $518.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from CELESTICA INC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.